DOCS Stock Overview
Designs, develops, procures, markets, sells, and distributes footwear under the Dr. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Dr. Martens plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.76 |
| 52 Week High | UK£1.00 |
| 52 Week Low | UK£0.49 |
| Beta | 0.058 |
| 1 Month Change | 30.49% |
| 3 Month Change | 19.19% |
| 1 Year Change | -15.11% |
| 3 Year Change | -80.88% |
| 5 Year Change | n/a |
| Change since IPO | -83.02% |
Recent News & Updates
Earnings Tell The Story For Dr. Martens plc (LON:DOCS) As Its Stock Soars 27%
Dec 06
Dr. Martens plc (LON:DOCS) Half-Yearly Results: Here's What Analysts Are Forecasting For This Year
Dec 01Recent updates
Earnings Tell The Story For Dr. Martens plc (LON:DOCS) As Its Stock Soars 27%
Dec 06Dr. Martens plc (LON:DOCS) Half-Yearly Results: Here's What Analysts Are Forecasting For This Year
Dec 01Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet
Sep 21Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?
Aug 20Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger
Jul 20There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings
Jun 19Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 21The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Mar 27Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet
Mar 06Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 08Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market
Jan 21Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
Oct 12Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Sep 13Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)
Jul 12A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Jun 02Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency
Feb 25Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?
Dec 17The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Oct 02Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively
Jul 04Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge
Jun 16Shareholder Returns
| DOCS | GB Luxury | GB Market | |
|---|---|---|---|
| 7D | -1.2% | 0.9% | -1.4% |
| 1Y | -15.1% | -5.6% | 4.6% |
Return vs Industry: DOCS underperformed the UK Luxury industry which returned -5.6% over the past year.
Return vs Market: DOCS underperformed the UK Market which returned 4.6% over the past year.
Price Volatility
| DOCS volatility | |
|---|---|
| DOCS Average Weekly Movement | 8.5% |
| Luxury Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DOCS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: DOCS's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 2,630 | Kenny Wilson | www.drmartensplc.com |
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens plc Fundamentals Summary
| DOCS fundamental statistics | |
|---|---|
| Market cap | UK£728.58m |
| Earnings (TTM) | UK£29.40m |
| Revenue (TTM) | UK£805.90m |
25.0x
P/E Ratio0.9x
P/S RatioIs DOCS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCS income statement (TTM) | |
|---|---|
| Revenue | UK£805.90m |
| Cost of Revenue | UK£277.90m |
| Gross Profit | UK£528.00m |
| Other Expenses | UK£498.60m |
| Earnings | UK£29.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jun 05, 2025
| Earnings per share (EPS) | 0.031 |
| Gross Margin | 65.52% |
| Net Profit Margin | 3.65% |
| Debt/Equity Ratio | 86.0% |
How did DOCS perform over the long term?
See historical performance and comparisonDividends
3.3%
Current Dividend Yield60%
Payout RatioDoes DOCS pay a reliable dividends?
See DOCS dividend history and benchmarks| Dr. Martens dividend dates | |
|---|---|
| Ex Dividend Date | Mar 06 2025 |
| Dividend Pay Date | Apr 08 2025 |
| Days until Ex dividend | 77 days |
| Days until Dividend pay date | 110 days |
Does DOCS pay a reliable dividends?
See DOCS dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 20:49 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dr. Martens plc is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Taylor | Barclays |
| David Roux | BofA Global Research |
| Louise Singlehurst | Goldman Sachs |